- Unternehmen
- Produkte
- Fachbereiche
- Services
- Investoren
- Kontakt
- Community
Elekta aims to provide the highest level of cancer treatment possible, which means combining the most advanced technology with the most effective treatment techniques. In addition to working with industry and academic leaders through collaborative sponsored research programs, Elekta has its own extensive research and development program, which has resulted in a patent portfolio covering many important innovations in cancer care.
依照第287条(a)的标题35 the United States Code, and Section 15 of the UK’s Intellectual Property Act 2014, the reader is hereby placed on notice of Elekta's intellectual property rights for the following products protected by granted patents in the United States and the United Kingdom.
Elekta aims to provide the highest level of cancer treatment possible, which means combining the most advanced technology with the most effective treatment techniques. In addition to working with industry and academic leaders through research programmes, Elekta also acquires mature technology which has been proven to increase treatment accuracy, enhance the patient experience or improve treatment outcomes.
Elekta understands the importance of intellectual property and the role it plays in encouraging innovation and entrepreneurialism, having an extensive patent portfolio which covers many of the most important innovations in cancer care of the last four decades. However, we are always seeking new opportunities to augment our product range and intellectual property portfolio.
If you have a patented or patent pending cancer treatment technology or system that you think Elekta might be interested in, we want to hear from you. Please send your inquiry along with any additional information and contact details by completing the form below:
